Respiratory virus season is in full swing across California, with several illnesses spreading across the state. Cases of ...
The Centers for Disease Control and Prevention (CDC) has recently reduced the number of recommended childhood vaccines.
As the Trump administration erodes U.S. infrastructure supporting infectious disease vaccines, mRNA heavyweight Moderna plans ...
Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
The University of Auckland is hosting the research as part of the Global COVID Vaccine Safety (GCoVS) Project. Scientists ...
A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...
The chair of a federal vaccine advisory panel charted a new course for the committee in a podcast released Thursday, ...
Analysts see greater upside in Novavax, while Moderna carries a ‘Hold’ rating despite stronger gains over the past year. ・Moderna was in focus after updated cancer vaccine data, while Novavax drew ...
Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...
Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...
In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...
As the 'crunchy mom' movement swells, it is emblematic of a mainstream embrace of vaccine skepticism and a broader lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results